Related Experiment Video
Updated: Feb 13, 2026

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
Published on: October 13, 2016
CRISPR/Cas9 Technology as an Emerging Tool for Targeting Amyotrophic Lateral Sclerosis (ALS)
Ewa Kruminis-Kaszkiel1, Judyta Juranek2, Wojciech Maksymowicz3
1Department of Pathophysiology, School of Medicine, Collegium Medicum, University of Warmia and Mazury, 10-900 Olsztyn, Poland. ewa.kruminis@uwm.edu.pl.
The CRISPR/Cas9 genome editing tool offers novel therapeutic strategies for amyotrophic lateral sclerosis (ALS). This review explores its principles, limitations, and applications in modeling and treating ALS, including SOD1-linked and sporadic forms.
Failed At:
2026-06-19T13:37:55.719779+00:00
Related Concept Videos
CRISPR
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
CRISPR/Cas9 Genome Editing
Emerging Adulthood
Lateralization
Introduction Cardiac Emergencies

